share_log

アンジェス:遺伝子治療用製品「コラテジェン」が米国FDAよりブレイクスルーセラピー(画期的新薬)指定のお知らせ

AnGes: Notice that the gene therapy product “Colategen” has been designated as a breakthrough therapy (revolutionary new drug) by the US FDA

JPX ·  Sep 18 02:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more